The Changing Face of Parkinson’s Disease Treatment: New Approvals, Emerging Agents, and Clinical Integration - CME

CME

Title: The Changing Face of Parkinson’s Disease Treatment: New Approvals, Emerging Agents, and Clinical Integration

Description: Parkinson’s disease (PD) is a complex, progressive condition that impacts millions of older adults worldwide. Now, with FDA-approved subcutaneous infusion therapies emerging, the landscape of PD management is evolving. These advances bring exciting new opportunities, but also raise important questions: How do these therapies work? Who are the right candidates? How can clinicians optimize efficacy while managing infusion-site events? In this forward-thinking program, two leading movement disorder neurologists will share practical insights on integrating these innovations into personalized care plans. From addressing real-world challenges like infusion-site reactions to understanding emerging therapeutic options, including D1/D5 partial agonists, and their potential place in care, they’ll translate cutting-edge science into actionable strategies for everyday practice. To bring the science to life, caregiver vignettes will spotlight the patient and caregiver experience, capturing the realities and challenges of navigating PD care in this new era.

Target Audience: The primary target audience for this activity are movement-disorder specialists and general neurologists (including NPs and PAs), and primary care providers (MDs/DOs/NPs/PAs).

Learning Objectives

Discuss the mechanisms, efficacy, safety, and delivery of newly approved subcutaneous therapies
Explain how to apply newly approved subcutaneous therapies in practice, including selecting patients who are likely to benefit and mitigating infusion-site reactions to optimize patient outcomes in PD
Describe the novel mechanisms of action of and the latest safety and efficacy data on emerging PD therapies

Disclosures and Disclaimers: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Accredited Providers

Commercial Support

Credit Information

Credit Type	Units / Unit Type	Board
AMA PRA Category 1 Credit	0.75 Credits	ACCME- Accreditation Council for Continuing Medical Education